Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for thalassemia
ChiCTR1800017139Phase 4Not yet recruiting
- Sponsor
- Wuzhou Workers' Hospital
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of thalidomide in Thalassaemia, sponsored by Wuzhou Workers' Hospital. Primary endpoints: Blood routine and Blood biochemistry. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
thalidomide
03
Conditions
Thalassaemia
Beyond the preview
Go deeper on ChiCTR1800017139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017139.